Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer

被引:64
|
作者
Rohrmann, S
Roberts, WW
Walsh, PC
Platz, EA
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
来源
PROSTATE | 2003年 / 55卷 / 02期
关键词
prostate cancer; family history; obesity; age;
D O I
10.1002/pros.10211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Little is known about predictors of prostate cancer severity in young men. Therefore, we examined whether family history and obesity influence risk of high-grade disease and extraprostatic extension in men < 55-years old. METHODS. Four hundred ninety-eight men aged < 55 years who had had a radical prostatectomy (1992-1999) by one surgeon were mailed a survey in 2000 to assess family history of PCa and anthropometrics. Body mass index (BMI kg/m(2)) was calculated as an indicator of obesity. Logistic regression was used to compute odds ratios (OR) for high-grade disease (Gleason score greater than or equal to 7) and extraprostatic extension. RESULTS. Of the 363 respondents, 35.8% had at least one first-degree relative with PCa. Men with a family history were younger at surgery than those without a family history (48.8 vs. 50.1 years, P < 0.001). After controlling for age, cigarette smoking, and race/ethnicity, men with an affected father had a lower risk of high-grade disease compared to those without an affected father (OR = 0.42,95% Cl 0.23-0.76). Risk of high-grade disease increased with increasing BMI, especially in men < 50-years old (P-trend = 0.02). Family history and BMI were not clearly associated with extraprostatic extension. CONCLUSIONS. After taking into account a younger age at presentation among men with a family history, young men with a family history of PCa were less likely to have high-grade disease. Obesity may be associated with a poorer histology in young men with PCa, especially in men younger than 50 years of age. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 50 条
  • [1] COMORBIDITY STATUS AS A PREDICTOR OF HIGH-GRADE DISEASE IN MEN WITH PROSTATE CANCER
    Daskivich, Timothy
    Skarecky, Douglas
    Ahlering, Thomas
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2016, 195 (04): : E32 - E33
  • [2] A nomogram for predicting extraprostatic extension in prostate cancer based on extraprostatic extension grade and clinical characteristics
    Ma, Quan
    Tian, Wei
    Lv, Shasha
    Fu, Yongna
    Wang, Hui
    He, Jiansong
    Chen, Yongliang
    JOURNAL OF MENS HEALTH, 2024, 20 (05) : 48 - 56
  • [3] FAMILY HISTORY OF PROSTATE CANCER DOES NOT INCREASE THE RISK OF DETECTION OF PROSTATE CANCER NOR HIGH GRADE DISEASE IN MEN UNDERGOING INITIAL PROSTATE BIOPSY
    Zaytoun, Osama
    Moussa, Ayman
    Hernandez, Adrian
    Shah, Gaurang
    Susan, Luay
    Jones, Stephen
    JOURNAL OF UROLOGY, 2011, 185 (04): : E814 - E814
  • [4] Finding a Place for Family History To Inform High-grade Prostate Cancer Risk
    Markt, Sarah C.
    Penney, Kathryn L.
    Schumacher, Fredrick R.
    EUROPEAN UROLOGY, 2022, 82 (02) : 170 - 171
  • [5] High-Grade Prostate Cancer and the Prostate Cancer Prevention Trial
    Logothetis, Christopher J.
    Schellhammer, Paul F.
    CANCER PREVENTION RESEARCH, 2008, 1 (03) : 151 - 152
  • [6] Association of cigarette smoking with extraprostatic prostate cancer in young men
    Roberts, WW
    Platz, EA
    Walsh, PC
    JOURNAL OF UROLOGY, 2003, 169 (02): : 512 - 516
  • [7] CLINICAL SIGNIFICANCE OF EXTRAPROSTATIC EXTENSION IN GRADE GROUP 1 PROSTATE CANCER
    Rezaee, Michael
    Pallauf, Maximilian
    Fletcher, Sean
    Han, Misop
    Pavlovich, Christian
    Epstein, Jonathan
    Allaf, Mohamad
    Trock, Bruce
    Singla, Nirmish
    JOURNAL OF UROLOGY, 2023, 209 : E1154 - E1155
  • [8] Finasteride and high-grade prostate cancer in the prostate cancer prevention trial
    Lucia, M. Scott
    Epstein, Jonathan I.
    Goodman, Phyllis J.
    Darke, Amy K.
    Reuter, Victor E.
    Civantos, Francisco
    Tangen, Catherine M.
    Parnes, Howard L.
    Lippman, Scott M.
    La Rosa, Francisco G.
    Kattan, Michael W.
    Crawford, E. David
    Ford, Leslie G.
    Coltman, Charles A., Jr.
    Thompson, Ian M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18): : 1375 - 1383
  • [9] Finasteride and High-Grade Prostate Cancer
    Edwards, Jonathan L.
    CANCER PREVENTION RESEARCH, 2009, 2 (02) : 185 - 185
  • [10] High-grade prostate cancer and finasteride
    Lebdai, Souhil
    Bigot, Pierre
    Azzouzi, Abdel-Rahmene
    BJU INTERNATIONAL, 2010, 105 (04) : 456 - 459